Semma Therapeutics was founded to develop therapies for patients who currently depend on insulin injections. The technology of generating insulin-producing beta cells discovered in the laboratory of Professor Douglas Melton has been exclusively licensed to the company.

The Boston-based firm is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.